10,083
Total Claims
$1.8M
Drug Cost
1,384
Beneficiaries
$1,333
Cost/Patient
Peer Comparison vs. 18,720 Cardiology providers
-13%
Cost per patient vs peers
$1,333 vs $1,524 avg
Brand vs Generic
100% generic
Brand: 0 claims · $0
Generic: 8,515 claims · $198K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 735 | $860K |
| Sacubitril/Valsartan | 262 | $308K |
| Rivaroxaban | 208 | $246K |
| Evolocumab | 110 | $113K |
| Empagliflozin | 30 | $37K |
| Alirocumab | 19 | $21K |
| Dabigatran Etexilate Mesylate | 24 | $14K |
| Ranolazine | 47 | $13K |
| Ticagrelor | 24 | $13K |
| Metoprolol Succinate | 576 | $13K |
| Atorvastatin Calcium | 677 | $12K |
| Icosapent Ethyl | 15 | $11K |
| Rosuvastatin Calcium | 462 | $9,116 |
| Clopidogrel Bisulfate | 454 | $7,120 |
| Carvedilol | 605 | $6,976 |
Prescribing Profile
66
Unique Drugs
$1.5M
Patient Profile
75
Avg Age
46%
Female
1.49
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data